Dr John Allan Calcagni, MD | |
3545 Aquamarine Dr, Deland, FL 32724-1251 | |
(386) 624-6222 | |
Not Available |
Full Name | Dr John Allan Calcagni |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 3545 Aquamarine Dr, Deland, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912129883 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083X0100X | Preventive Medicine - Occupational Medicine | MD00031366 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Allan Calcagni, MD 3545 Aquamarine Dr, Deland, FL 32724-1251 Ph: (386) 624-6222 | Dr John Allan Calcagni, MD 3545 Aquamarine Dr, Deland, FL 32724-1251 Ph: (386) 624-6222 |
News Archive
US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound (HIFU) technologies, announced today its exclusive partnership with Riverside Research Institute (RRI) to develop and test an ultrasonic method of prostate imaging and treatment that combines advanced tissue-type imaging with ultrasound energy from the Sonablate® 500 medical device.
Two University of Rhode Island scientists have revealed how a cancer causing protein is regulated by reactive oxygen species (ROS) - a type of stress signal.
A new study conducted by researchers at the University of Eastern Finland found that the PLCG2-P522R genetic variant, which protects against Alzheimer's disease, enhances several key functions of immune cells. The results obtained in the study highlight the importance of immune cells as a target of future development of new therapies for Alzheimer's disease.
The Society of Gynecologic Oncologists (SGO) will host its 41st Annual Meeting on Women's Cancer March 14-17, 2010 at the Moscone West Convention Center in San Francisco, California. This year's meeting will feature more than 434 scientific presentations in addition to lectures, workshops, symposia and postgraduate courses that focus on emerging science, clinical trials and treatment advances for physicians and health care professionals in the field of gynecologic oncology.
› Verified 9 days ago